Bertina RM - Search Results

1

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.

Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM. Høibraaten E, et al. Among authors: bertina rm. Br J Haematol. 2001 Nov;115(2):415-20. doi: 10.1046/j.1365-2141.2001.03111.x. Br J Haematol. 2001. PMID: 11703344 Free article. Clinical Trial.

2

Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation.

Legnani C, Palareti G, Biagi R, Coccheri S, Bernardi F, Rosendaal FR, Reitsma PH, de Ronde H, Bertina RM. Legnani C, et al. Among authors: bertina rm. Br J Haematol. 1996 Jun;93(3):694-9. doi: 10.1046/j.1365-2141.1996.d01-1709.x. Br J Haematol. 1996. PMID: 8652396

3

Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation.

de Ronde H, Bertina RM. de Ronde H, et al. Among authors: bertina rm. Blood Coagul Fibrinolysis. 1999 Jan;10(1):7-17. doi: 10.1097/00001721-199901000-00002. Blood Coagul Fibrinolysis. 1999. PMID: 10070830

4

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Dahm A, et al. Among authors: bertina rm. Blood. 2003 Jun 1;101(11):4387-92. doi: 10.1182/blood-2002-10-3188. Epub 2003 Jan 30. Blood. 2003. PMID: 12560220 Free article.

5

Venous thrombotic risk in family members of unselected individuals with factor V Leiden.

Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Lensen RP, et al. Among authors: bertina rm. Thromb Haemost. 2000 Jun;83(6):817-21. Thromb Haemost. 2000. PMID: 10896231

6

Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria.

de Ronde H, Bertina RM. de Ronde H, et al. Among authors: bertina rm. Thromb Haemost. 1994 Dec;72(6):880-6. Thromb Haemost. 1994. PMID: 7740458

7

Mutation in blood coagulation factor V associated with resistance to activated protein C.

Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Bertina RM, et al. Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0. Nature. 1994. PMID: 8164741 Free article.

8

The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction.

Haan J, Kappelle LJ, de Ronde H, Ferrari MD, Bertina RM. Haan J, et al. Among authors: bertina rm. Cephalalgia. 1997 Aug;17(5):605-7. doi: 10.1046/j.1468-2982.1997.1705605.x. Cephalalgia. 1997. PMID: 9251878

9

Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds.

Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Simioni P, et al. Among authors: bertina rm. Stroke. 1995 May;26(5):885-90. doi: 10.1161/01.str.26.5.885. Stroke. 1995. PMID: 7740584

10

Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.

van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM. van Vliet HA, et al. Among authors: bertina rm. J Thromb Haemost. 2008 Feb;6(2):346-51. doi: 10.1111/j.1538-7836.2008.02863.x. Epub 2007 Dec 7. J Thromb Haemost. 2008. PMID: 18067603 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters